Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial

Cannabis Stocks

EXCLUSIVE: Cannabis ETF Leaders Highlight Convenience For Investors, Growth Opportunities — 'I Don't Think Cannabis Is Uninvestable'
EXCLUSIVE: Cannabis ETF Leaders Highlight Convenience For Investors, Growth Opportunities — 'I Don't Think Cannabis Is Uninvestable'
Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year'
Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year'
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year'
Cronos Stock Surges On Q1 Earnings Beat, 'Strong' Demand For Flower Products: '2025 Is Shaping Up To Be A Transformative Year'
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
Why Cannabis Stocks Jumped By Double Digits And Why Analysts Say 'Don't Drink The Kool-Aid In One Gulp'
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Cannabis Stock Valuations Reflect No Expectation Of Federal Reform: Study
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector
Amplify To Liquidate Cannabis-Focused MJUS ETF As Regulatory Uncertainty Weighs On Sector

Cannabis Stocks Recent News

Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?
For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.
Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?
Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?
Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.
NASDAQ-Listed Weed Stock, High Tides Surges Over 21% In Last Two Sessions
NASDAQ-Listed Weed Stock, High Tides Surges Over 21% In Last Two Sessions
Data from Benzinga Pro shows High Tide Inc. shares experienced a significant surge, gaining over 21% in the last two trading sessions.
Jupiter's Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?
Jupiter's Burnout: Can TILT Holdings Reverse Its Five-Year Vape Decline?
TILT's financial health is constrained by $62 million in debt, along with $44 million in lease obligations.
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
The AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
Canopy USA offers investors exposure to the U.S. cannabis market without direct regulatory risk through brands like Wana and Jetty.
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
Shareholder Lawsuit Challenges Tilray's Voting Tactics For Authorized Share Increase
Tilray faces a new shareholder lawsuit accusing the company of misleading voting practices, following a $39.9M settlement over similar issues
Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabis
Cronos CEO Mike Gorenstein Says He's Optimistic About Trump's Impact On Cannabis
Cronos CEO Mike Gorenstein discusses Trump's potential for cannabis reform, challenges the "blue state" myth, and Cronos' focus...
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Trump Nominates Another Cannabis Supporter To Cabinet: Rep. Matt Gaetz For Attorney General
Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.
Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?
Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?
Cannabis giants Village Farms, Green Thumb, and Jushi Holdings show distinct strategies for navigating a challenging landscape. 
Planet 13 Slashes Costs 66%: Revenue Grows, Losses Shrink — Is This The Turning Point?
Planet 13 Slashes Costs 66%: Revenue Grows, Losses Shrink — Is This The Turning Point?
Despite consumer spending challenges, co-CEO Bob Groesbeck pointed out the strategic focus on cash flow and scaling its footprint.
Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?
Cannabis Stocks Plunged After Florida Legalization Failed: Rational Reaction Or Market Overreach?
Florida's failed adult-use cannabis vote led to a $2.6B loss in market cap. Was the market reaction justified? Earnings data adds uncertainty.
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Curaleaf Q3 Results: Strong Margins But $44M Loss, What's Next For Investors?
Curaleaf Q3 Results: Strong Margins But $44M Loss, What's Next For Investors?
The company reported a net loss of $44 million, equivalent to $0.07 per share, with adjusted EBITDA at $75.3 million.Curaleaf Holdings, Inc. (OTC:CURLF) posted its third-quarter revenue of $331 million on Wednesday afternoon, marking a modest 1% year-over-year decline.
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
Tilray, Trulieve And Other Cannabis Stocks Nosediving As Industry Faces New Wave Of Political Uncertainty
Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.
Trump, Harris And Cannabis Stocks: Are Election Results Already Priced In?
Trump, Harris And Cannabis Stocks: Are Election Results Already Priced In?
Cannabis stocks: As election day approaches, they face volatility amid Trump's rising poll numbers and market skepticism about his stance.
Don't Be Fooled By Flashy Numbers: Read Between The Lines With This Guide To Cannabis Earnings Reports
Don't Be Fooled By Flashy Numbers: Read Between The Lines With This Guide To Cannabis Earnings Reports
Understanding these financial statements enables you to assess a cannabis company's performance and recognize growth or red flags.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved